Trial reportJournal of pain and symptom management2008
Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance.
Trial report in Journal of pain and symptom management, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02420561 (Motivational Interviewing to Reduce Substance Use Among Depression Patients), which is not on this map. Cited by 34 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Motivational Interviewing to Reduce Substance Use Among Depression Patients
Who cites it
34 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2017Pooled it
- Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.The journal of pain · 2015Pooled it
- Pooled it
- American Society for Pain Management nursing position statement: pain management in patients with substance use disorders.Journal of addictions nursing · 2012Guideline
- Clinical Instruments Assessing Harms and Benefits of Long-Term Opioid Therapy for Chronic Pain: A Scoping Review.Journal of general internal medicine · 2026Article
- Consensus statement on chronic pain treatment in cancer survivors.Journal of anesthesia · 2025Review
- Resentful, Resigned and Respectful: Opioid Analgesics, Pain and Control, a Qualitative Study.Pharmacy (Basel, Switzerland) · 2025Article
- Investigating Whether a Combination of Electro-Encephalography and Gene Expression Profiling Can Predict the Risk of Chronic Pain: A Protocol for an Observational Prospective Cohort Study.Brain sciences · 2024Article
- Patient-centered Engagement as a Mediator in the Associations of Healthcare Discrimination, Pain Care Denial, and Later Substance Use Among a Sample of Predominately African Americans Living with HIV.AIDS and behavior · 2024Article
- Patients' perspectives on tapering programmes for prescription opioid use disorder: a qualitative study.BMJ open · 2023Article
- Algorithms to Identify Nonmedical Opioid Use.Current pain and headache reports · 2023Review
- Learning from addiction: Craving of prescription opioids in chronic pain sufferers.Neuroscience and biobehavioral reviews · 2022Review
- Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now.The Korean journal of pain · 2022Review
- Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain.JAMA network open · 2021Article
- A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2021Article
- A Brief Screening Tool for Opioid Use Disorder: EMPOWER Study Expert Consensus Protocol.Frontiers in medicine · 2021Article
- French-Canadian translation of a self-report questionnaire to monitor opioid therapy for chronic pain: The Opioid Compliance Checklist (OCC-FC).Canadian journal of pain = Revue canadienne de la douleur · 2020Article
- Evaluation of the Preliminary Validity of Misuse of Prescription Pain Medication Items from the Patient-Reported Outcomes Measurement Information System (PROMIS)®.Pain medicine (Malden, Mass.) · 2019Article
- Emotion dysregulation as an explanatory factor in the relation between negative affectivity and non-medical use of opioid in a diverse young adult sample.Addictive behaviors · 2019Article
- Physician's role in prescribing opioids in developing countries.BMJ case reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Prescription Drug Use Questionnaire (PDUQ) is one of several published tools developed to help clinicians better identify the presence of opioid abuse or dependence in patients with chronic pain. This paper introduces a patient version of the PDUQ (PDUQp), a 31-item questionnaire derived from the items of the original tool designed for self-administration, and describes evidence for its validity and reliability in a sample of patients with chronic nonmalignant pain and on opioid therapy. Further, this study examines instances of discontinuation from opioid medication treatment related to violation of the medication agreement in this population, and the relationship of these with problematic opioid misuse behaviors, PDUQ and PDUQp scores. A sample of 135 consecutive patients with chronic nonmalignant pain was recruited from a multidisciplinary Veterans Affairs chronic pain clinic, and prospectively followed over one year of opioid therapy. Using the PDUQ as a criterion measure, moderate to good concurrent and predictive validity data for the PDUQp are presented, as well as item-by-item comparison of the two formats. Reliability data indicate moderate test stability over time. Of those patients whose opioid treatment was discontinued due to medication agreement violation-related discontinuation (MAVRD) (n=38 or 28% of sample), 40% of these (n=11) were due to specific problematic opioid misuse behaviors. Based upon specificity and sensitivity analyses, a suggested cutoff PDUQp score for predicting MAVRD is provided. This study supports the PDUQp as a useful tool for assessing and predicting problematic opioid medication use in a chronic pain patient sample.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.